1. Home
  2. GNPX vs ZKIN Comparison

GNPX vs ZKIN Comparison

Compare GNPX & ZKIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNPX
  • ZKIN
  • Stock Information
  • Founded
  • GNPX 2009
  • ZKIN 2015
  • Country
  • GNPX United States
  • ZKIN China
  • Employees
  • GNPX N/A
  • ZKIN N/A
  • Industry
  • GNPX Biotechnology: Pharmaceutical Preparations
  • ZKIN Metal Fabrications
  • Sector
  • GNPX Health Care
  • ZKIN Industrials
  • Exchange
  • GNPX Nasdaq
  • ZKIN Nasdaq
  • Market Cap
  • GNPX 10.8M
  • ZKIN 9.9M
  • IPO Year
  • GNPX 2018
  • ZKIN 2017
  • Fundamental
  • Price
  • GNPX $6.64
  • ZKIN $2.19
  • Analyst Decision
  • GNPX
  • ZKIN
  • Analyst Count
  • GNPX 0
  • ZKIN 0
  • Target Price
  • GNPX N/A
  • ZKIN N/A
  • AVG Volume (30 Days)
  • GNPX 1.7M
  • ZKIN 38.9K
  • Earning Date
  • GNPX 11-14-2025
  • ZKIN 09-29-2025
  • Dividend Yield
  • GNPX N/A
  • ZKIN N/A
  • EPS Growth
  • GNPX N/A
  • ZKIN N/A
  • EPS
  • GNPX N/A
  • ZKIN N/A
  • Revenue
  • GNPX N/A
  • ZKIN $95,309,093.00
  • Revenue This Year
  • GNPX N/A
  • ZKIN N/A
  • Revenue Next Year
  • GNPX N/A
  • ZKIN N/A
  • P/E Ratio
  • GNPX N/A
  • ZKIN N/A
  • Revenue Growth
  • GNPX N/A
  • ZKIN N/A
  • 52 Week Low
  • GNPX $6.51
  • ZKIN $0.82
  • 52 Week High
  • GNPX $140.00
  • ZKIN $6.30
  • Technical
  • Relative Strength Index (RSI)
  • GNPX 63.07
  • ZKIN 47.87
  • Support Level
  • GNPX $7.71
  • ZKIN $2.11
  • Resistance Level
  • GNPX $9.89
  • ZKIN $2.41
  • Average True Range (ATR)
  • GNPX 1.15
  • ZKIN 0.24
  • MACD
  • GNPX 0.53
  • ZKIN -0.02
  • Stochastic Oscillator
  • GNPX 50.54
  • ZKIN 37.33

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About ZKIN ZK International Group Co. Ltd

ZK International Group Co Ltd is engaged in the manufacture and marketing of metal pipes. The company is specialized in producing double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, single-press tubes and fittings, and stainless-steel strips. The products are used in restaurants, hotels, hospitals, firefighting, food, beverage, ships, engines, industrial seawater desalination and systems of direct-drinking water, cold /hot water supply, city water supply, and gas of large/middle scale construction projects.

Share on Social Networks: